Bio-Techne Investor Relations Material
Latest events
Q2 2024
Bio-Techne
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Bio-Techne Corporation
Access all reports
Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the research, and diagnostics and bioprocessing markets worldwide. The company offers reagents used in a variety of applications including cell separation core processing; animal cell culture; protein expression and purification; automated liquid handling systems for genomics and proteomics; scientific discovery instruments for chemical analysis and process development; and basic biological research supplies. It also provides instrumentation used to hold microplates; perform plate-based lab assays; feed and mix liquid samples into plate-based assays; read out the results from automated assays on plates; generate plate-based assay data from central readers to cloud based clinical databases or laboratory information systems. In addition, the company offers thermoformers used in thermoforming applications including film manufacturing for food packaging applications; electronics such as integrated circuit packaging, electronic circuit board printing, clean room laminating sheeting, etc.; and biomedical packaging applications. Bio-Techne Corporation is headquartered in San Jose, California.
Key slides for Bio-Techne Corporation
Investor Day 2023
Bio-Techne Corporation
Investor Day 2023
Bio-Techne Corporation
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States